# Target Corporation

Type: Company (TGT)

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/target-corporation
Canonical HTML page: https://getbiobrief.com/entity/target-corporation

## Recent coverage (2 stories)

### 500+ Tylenol suits revived: $10B risk for Kenvue and OTC pharma
2026-07-25 19:56:51 · Sentiment: Negative · Impact: 7/10 · Sources: 2

The 2nd Circuit ruling revives mass tort litigation linking prenatal acetaminophen to autism, exposing Kenvue and retailers to billions in potential liability. The decision hinges on admissibility of novel scientific evidence, challenging Daubert standards and regulatory orthodoxy.
Full story: https://getbiobrief.com/story/tylenol-autism-lawsuits-revived-bio

### 3 Infant Botulism Cases Trigger Nara Organics Voluntary Recall
2026-06-15 09:51:27 · Sentiment: Strongly negative · Impact: 7/10 · Sources: 2

A cluster of three infant botulism cases, despite zero positive C. botulinum tests in product lots, has forced Nara Organics to recall all whole milk powdered formula. The incident raises critical quality control and sterility challenges for the organic infant nutrition sector.
Full story: https://getbiobrief.com/story/nara-organic-formula-recall-botulism-bio

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.